Anti-inflammatory Effect of Fermented Red Ginseng Via Regulation of NF-${\kappa}$B Signal Transduction

발효 홍삼의 NF-${\kappa}$B 신호전달 조절을 통한 항염증 효과

  • 황성인 (부산대학교 한의학전문대학원) ;
  • 주현정 (부산대학교 한의학전문대학원) ;
  • 김효동 (부산대학교 한의학전문대학원) ;
  • 곽태원 (부산대학교 한의학전문대학원) ;
  • 유병홍 ((주)바이오포트코리아) ;
  • 김성구 ((주)바이오포트코리아) ;
  • 이철원 (부산대학교 해양생물기술연구소) ;
  • 황태호 (부산대학교 한의학전문대학원) ;
  • 안원근 (부산대학교 한의학전문대학원)
  • Received : 2011.05.27
  • Accepted : 2011.06.13
  • Published : 2011.06.25

Abstract

Recently, Korean ginseng, as immuno-activator, was actively investigated on its effect and mechanism. But purified fermented red ginseng (PFRG) has not been researched enough compared to red ginseng (RG, steamed and dried root of Panax ginseng C. A. Meyer, family Araliaceae) and fermented red ginseng (FRG, fermented red ginseng by Lactobacillus brevis 13094). In this study, we examined RG, FRG and PFRG to compare their anti-inflammatory effect by LPS. According to the result, RAW 264.7 cells survival rates did not largely change by RG and FRG. Only PFRG expressed weak toxicity at 10 ug/ml. The expression of iNOS and production of Nitric Oxide (NO) decreased depending on the concentration of RG, FRG and PFRG. And the expression of COX-2 also decreased. We tried western blotting for detecting that the expression of iNOS, COX-2 was caused by NF-${\kappa}B$. The result supported that the inhibition of NF-${\kappa}B$ by RG, FRG and PFRG suppressed the expression of iNOS, COX-2 and affected the production of TNF-${\alpha}$. While the anti-inflammatory effect was confirmed from all three types of red ginseng (RG, FRG, PFRG), the effect of PFRG was superior to others. Further research is required on other effects of PFRG.

Keywords

References

  1. Xiaoguang, C., Hongyan, L., Xiaohong, L., Zhaodi, F., Yan, L., Lihua, T., Rui, H. Cancer chemopreventive and therapeutic activities of red ginseng. J. Ethnopharmacol 60: 71-78, 1998. https://doi.org/10.1016/S0378-8741(97)00133-5
  2. 조재열. 홍삼 유해 성분들의 면역조절 효능. 한국식품저장유통학회. 8(2):6-12, 2009.
  3. Cho, W.C., Chung, W.S., Lee, S.K., Leung, A.W., Cheng, C.H., Yue, K.K. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol 550: 173-179, 2006. https://doi.org/10.1016/j.ejphar.2006.08.056
  4. Jang, S.K., Kim, J.H., Chung, Y.S., Ahn, D.C., Kang, M.J., Lee, D.G., Kim, S.H. An Experimental Study on the Effect of Immunopotential and the Anticancer Effect of Red Ginseng Extract. J. Ginseng Res 18: 151-159, 1994.
  5. Shao, Z.H., Xie, J.T., Vanden Hoek, T.L., Mehendale, S., Aung, H., Li, C.Q., Qin, Y., Schumacker, P.T., Becker, L.B., Yuan, C.S. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. Biochim Biophys Acta 1670: 165-171, 2004. https://doi.org/10.1016/j.bbagen.2003.12.001
  6. Bae, E.A., Han, M.J., Baek, N.I., Kim, D.H. In vitroanti-Helicobacter pylori activity of panaxytriol isolate from ginseng. Arch Pharm Res 24: 297-299, 2001. https://doi.org/10.1007/BF02975095
  7. Park, E.K., Choo, M.K., Han, M.J., Kim, D.H. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Imm 133: 113-120, 2004. https://doi.org/10.1159/000076383
  8. Jeon, B.S., Park, J.W., Kim, B.K., Kim, H.K., Jung, T.S., Hahm, J.R., Kim, D.R., Cho, Y.S., Cha, J.Y. Fermented mushroom milk supplemented dietary fiber prevents the onset of obesity and hypertriglyceridemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Diabetes Obes. Metab 7: 709-715, 2005. https://doi.org/10.1111/j.1463-1326.2005.00456.x
  9. Nam, K.Y. The comparative understanding between red ginseng and white ginsengs, processed ginsengs(panax ginseng C. A. Meyer). J. Ginseng Res 29: 1-18, 2005. https://doi.org/10.5142/JGR.2005.29.1.001
  10. 김동청, 황우익, 인만진, 이성동. 인삼의 지용성 추출물 투여가 면역기능에 미치는 영향. J Ginseng Res 32(1):19-25, 2008. https://doi.org/10.5142/JGR.2008.32.1.019
  11. Szabo, C., Ohshima, H. DNA domage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1: 373-385, 1997. https://doi.org/10.1006/niox.1997.0143
  12. McCann, S.M., Mastronardi, C., de Laurentiis, A., Rettori, V. The nitric oxide theory of aging revisited. Ann NY Acad Sci 1057: 64-84, 2005. https://doi.org/10.1196/annals.1356.064
  13. Nathan, C.F. Secretory products of macrophages. J Clin Invest 79: 319-326, 1987. https://doi.org/10.1172/JCI112815
  14. Salvemini, D., Korbut, R., Anggard, E., Vane, J. Imminediate release of a nitric oxide-like factor from bovine aortic endothelial cells. Proc Natl Acad Sci USA. 87(7):2593-2597, 1990. https://doi.org/10.1073/pnas.87.7.2593
  15. Dennis J. Stuehr, Michael A. Maretta. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-$\gamma$. J. immunol 139(2):518-525, 1987.
  16. Kuo, C.T., Chiang, L.L., Lee, C.N., Yu, M.C., Bai, K.J., Lee, H.M., Lee, W.S., Sheu, J.R., Lin, C.H. Induction of nitric oxide synthase in Raw 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus. Invovement of protein kinase C- and Nuclear factor-$\kappa$B-dependent machanisms. J Biomed Sci 10: 136-145, 2003.
  17. Lorsbach, R.B., Murphy, W.J., Lowenstein, C.J., Snyder, S.H., Russell, S.W. Expression of the nitric oxide synthase gene in mouse macrophage activated for tumor cell killing. J Biol Chem 268(3):1908-1913, 1993.
  18. Stork, M., Schilling, M., Burkhardt, K., Prestel, R., Abendroth, D., Hammer, C. Production of proinflammatory cytokines and adhesion molecules on ex-vivo xenogeneic kidney perfusion. Transpl Int 7(1):647-649, 1994. https://doi.org/10.1111/j.1432-2277.1994.tb01464.x
  19. Moncada, S., Palmer, R.M., Higgs, E.A. Nitric oxide: physiology. pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
  20. Baeurle, P.A. I$\kappa$B-NF-$\kappa$B structure: at the interface of inflammation control. Cell 95: 729-731, 1998. https://doi.org/10.1016/S0092-8674(00)81694-3
  21. Knowles, R.G., Moncada, S. Nitric oxide as a signal in blood vessels. TIBS 17: 399-402, 1992.
  22. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992. https://doi.org/10.1096/fasebj.6.12.1381691
  23. McCartney-Francis, N., Allen, J.B., Mizel, D.E., Albina, J.E., Xie, Q.W., Nathan, C.F., Wahl, S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178: 749-754, 1993. https://doi.org/10.1084/jem.178.2.749
  24. Harris, S.G., Padilla, J., Koumas, L., Ray, D., Phipps, R.P. Prostaglandins as modulators of immunity. Trends Immunol 23: 144-150, 2002. https://doi.org/10.1016/S1471-4906(01)02154-8
  25. 현미선, 허정무, 신용서, 손봉준, 문연자, 우원홍. RAW 264.7 세포에서 LPS에 의해 유도된 염증에 대한 백삼, 홍삼, 발효홍삼의 항염효과에 대한 비교 연구. 한국응용생명화학회 52(1):21-27, 2009. https://doi.org/10.3839/jabc.2009.004
  26. Guzik, T.J., Channon, K.M. Measurement of vascular reactive oxygen species production by chemiluminescence. Method Mol Med 108: 73-89, 2005.
  27. Rachmilewitz, D., Stamler, J.S., Karmeli, F., Mullins, M.E., Singel, D.J., Loscalzo, J., Xavier, R.J., Podolsky, D.K. Peroxynitrite-induced rat colitis-a new model of colonic inflammation. Gastroenterology 105(6):1681-1688, 1993. https://doi.org/10.1016/0016-5085(93)91063-N
  28. Berg, J., Fellier, H., Christoph, T., Grarup, J., Stimmeder, D. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm Res 48: 369-379, 1999. https://doi.org/10.1007/s000110050474
  29. Aggarwal, B.B. Nuclear factor-$\kappa$B: The enemy within. Cancer Cell 6: 203-208, 2004. https://doi.org/10.1016/j.ccr.2004.09.003
  30. Cruz, M.T., Duarte, C.B., Gonçalo, M., Figueiredo, A., Carvalho, A.P., Lopes, M.C. Granulocyte - macrophage colony-stimulating factor activates the transcription of nuclear factor kappa B and induces the expression of nitric oxide synthase in a skin dendritic cell line. Immunol Cell Biol 79: 590-596, 2001. https://doi.org/10.1046/j.1440-1711.2001.01041.x
  31. Beutler, B., Cerami, A. The biology of cachectin/TNF-$\alpha$ primary mediator of the host response. Annu Rev Immunol 7: 625-655, 1989. https://doi.org/10.1146/annurev.iy.07.040189.003205
  32. Guslandi, M. Nitric oxide and inflammatory bowel diseases. Eur J Clin Invest 28: 904-907, 1998. https://doi.org/10.1046/j.1365-2362.1998.00377.x
  33. Albina, J.L., Reichner, J.S. Role of nitric oxide mediation of macrophage cytotoxicity and apoptosis. Cancer Metast Rev 17: 39-53, 1998. https://doi.org/10.1023/A:1005904704618